NCT06351527 2025-06-19Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell MalignanciesInnoCare Pharma Inc.Phase 1 Recruiting78 enrolled